New insight on hearing development in children
A new study from Oregon Health & Science University is the first to suggest that binaural pitch fusion—a process that ...
Envoy Medical secures new patents for cochlear implants
Inc. (NASDAQ: COCH), a small-cap medical device company with a market capitalization of $29.4 million specializing in hearing loss solutions, has announced the expansion of its patent portfolio with ...
Envoy Medical Secures Additional Patent Protection for Its Growing Patent Portfolio
The Hong Kong Patent Office granted HK Patent No. HK40097814 to Envoy Medical Corporation on January 3, 2025. The title is Programming of Cochlear Implant Accessories. This patent relates to a system ...
Cochlear stock rating cut at RBC Capital, target to AUD312
RBC Capital markets adjusted their stance on Cochlear Ltd. (COH:AU) (OTC: CHEOY), a $10.9 billion medical device company ...
Cochlear targets 50,000 implant recipients in FY 2025 with new product launches and cloud investments
Discover Cochlear Limited's Q2 2025 earnings insights: strong implant growth, upcoming product launches, and strategic investments amid Services ...
Cochlear share price sinks 10% on half-year result disappointment
The Cochlear Ltd (ASX: COH) share price is sinking on Friday after the hearing solutions company's half year result ...